Inhibition of SRC-3 as a potential therapeutic strategy for aggressive mantle cell lymphoma. Bijou I, Liu Y, Lu D, Chen J, et al. PLoS One 2024;19:e0289902.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bijou I, Liu Y, Lu D, Chen J, et al. Inhibition of SRC-3 as a potential therapeutic strategy for aggressive mantle cell lymphoma. PLoS One 2024;19:e0289902.
PMID: 38683834